Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck’s molnupiravir
Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults
Previous
Previous
National Institute on Alcohol Abuse & Alcoholism: Rethinking Your Holiday Drinking
Next
Next